Skip to content

Triomune approved for PEPFAR use

Tipranavir falls between two stools in naïve trial

TMC125 study highlights risk of staying on failing NNRTI regimen

Genetically modified HIV shows early promise as a gene therapy viral vector

Radioimmunotherapy clears HIV-infected cells in mice

Brazil begins negotiations over Kaletra price again

Second generic abacavir approved for PEPFAR

Kaletra tablets better tolerated, patient survey finds

Merck buys protease inhibitor from Ambrilia, may be potent booster of other PIs